The global sinus dilation devices market was valued at USD 2.74 billion in 2022, with an anticipated growth rate of 9.6% CAGR from 2023 to 2030. This growth is largely driven by an increasing preference for minimally invasive procedures, favorable reimbursement policies, greater awareness of the benefits of balloon sinuplasty over traditional methods, and the high prevalence of chronic sinusitis. The development of advanced surgical techniques has improved patient outcomes and accelerated the replacement of traditional methods, boosting the demand for sinus dilation devices.

One notable area of technological advancement in sinus surgery is the use of surgical lasers. These advancements help ensure minimal ablation, which results in fewer side effects and enables procedures to be completed quickly, often in outpatient settings. For instance, the UK's National Health Service (NHS) introduced a novel laser treatment for epilepsy patients in 2022, highlighting the importance of laser technology in providing innovative, effective treatment options and improving patients' quality of life.

The COVID-19 pandemic significantly disrupted routine healthcare services, including treatments for chronic rhinitis and other sinus-related issues. Many healthcare facilities postponed elective surgeries and routine visits to prioritize the availability of intensive care and inpatient beds for COVID-19 patients. This shift in healthcare priorities led patients with sinus issues to seek alternative care methods, including teleconsultations and temporary remedies.

Gather more insights about the market drivers, restrains and growth of the Sinus Dilation Devices Market

Regional Insights:

North America Sinus Dilation Devices Market Trends

North America led the sinus dilation devices market in 2022, contributing over 40% of global revenue. This dominance is due to the region’s highly developed healthcare infrastructure and the availability of advanced products from major companies in the sector. The U.S. healthcare system, for instance, is a mix of public and private services. Government programs like Medicare and Medicaid provide coverage for specific groups, while most individuals obtain private health insurance, often through employers. The Affordable Care Act has contributed to a decline in the uninsured population by expanding coverage options. Public and private insurers in the U.S. determine coverage and costs under federal and state regulations, creating a comprehensive system with both government-funded and private insurance options.

Asia Pacific Sinus Dilation Devices Market Trends

The Asia Pacific region is expected to see the fastest market growth, with a projected CAGR of 10.4% from 2023 to 2030. Key factors driving this growth include rising disposable incomes and increased awareness of sinus treatment options. According to a report by the Organization for Economic Co-operation and Development (OECD), emerging Asian countries such as China, India, and the ASEAN-10 nations showed economic resilience during the COVID-19 pandemic and global economic downturn. Their economies are projected to grow by 5.3% in 2023 and 5.4% in 2024, with ASEAN economies expected to grow by around 4.6% in 2023 and 4.8% in 2024, highlighting their ability to rebound and sustain economic progress.

Browse through Grand View Research's Category Medical Devices Industry Research Reports.

• The global pediatric clinical trials market size was estimated at USD 19.9 billion in 2024 and is projected to grow at a CAGR of 5.25% from 2025 to 2030.
• The global non-alcoholic steatohepatitis clinical trials market size was estimated at USD 2.92 billion in 2024 and is projected to grow at a CAGR of 6.26% from 2025 to 2030.

Key Companies & Market Share Insights:

Major players in the sinus dilation devices market are pursuing various growth strategies, including mergers and acquisitions, technological innovations, promotional activities, and device enhancements. For example, Intersect ENT, Inc., a prominent provider of medical technology for ear, nose, and throat care, introduced a new product in the U.S. market that combines the Straight Delivery System (SDS) with the PROPEL Mini Sinus Implant. This combined system received approval from the U.S. Food and Drug Administration (FDA) in July 2020, making it available for use in clinical settings. By developing and launching FDA-approved devices, Intersect ENT and other companies can expand their offerings and cater to the increasing demand for advanced sinus dilation solutions.

In summary, the sinus dilation devices market is experiencing growth driven by the demand for minimally invasive solutions, supportive reimbursement policies, and innovations in surgical technology. North America holds a dominant position due to its established healthcare infrastructure, while Asia Pacific is poised for rapid expansion as awareness and economic growth support greater healthcare access and innovation.

Key Sinus Dilation Devices Companies:

• Medtronic
• Smith+Nephew
• Stryker
• Intersect ENT, Inc
• Olympus Corporation
• SinuSys Corporation
• Johnson & Johnson Services, Inc.
• TE Connectivity
• InnAccel Technologies Pvt Ltd

Order a free sample PDF of the Sinus Dilation Devices Market Intelligence Study, published by Grand View Research.